139th National Cancer Advisory Board
NATIONAL CANCER ADVISORY BOARD BETHESDA, MARYLAND Summary of Meeting September 6-7, 2006
The National Cancer Advisory Board (NCAB) convened for its 139th regular meeting on Wednesday, September 6, 2006, in Conference Room 10, C Wing, Building 31, National Institutes of Health (NIH), Bethesda, MD. The meeting was open to the public on Wednesday, September 6, 2006, from 8:30 a.m. to 4:30 p.m. The meeting was closed to the public from 4:30 p.m. until adjournment at 5:30 p.m. The meeting was open to the public on Thursday, September 7, from 8:00 a.m. until adjournment at 12:00 noon. NCAB Chair Dr. Carolyn D. Runowicz, Director, The Carole and Ray Neag Comprehensive Cancer Center, Farmington, CT, presided during both the open and closed sessions.
NCAB Members Dr. Carolyn D. Runowicz (Chair) Dr. Anthony Atala (absent) Dr. Bruce Allan Chabner Dr. Moon S. Chen, Jr. Dr. Donald S. Coffey Dr. Kenneth H. Cowan Dr. Jean B. deKernion (absent) Dr. Lloyd K. Everson Dr. Judah Folkman (absent) Dr. Ralph S. Freedman Ms. Kathryn Giusti Mr. Robert A. Ingram Mr. David Koch (absent) Dr. Diana M. Lopez Dr. Karen Dow Meneses Dr. Franklyn G. Prendergast (absent) Ms. Lydia G. Ryan Dr. Daniel D. Von Hoff
President’s Cancer Panel Dr. LaSalle D. Leffall, Jr. (Chairperson) Mr. Lance E. Armstrong (absent) Dr. Margaret Kripke (absent)
Alternate Ex Officio NCAB Members Dr. Michael Babich, CPSC Dr. Allen Dearry, NIEHS Ms. Diane Jones, OSTP (absent) Dr. Raynard Kington, NIH (absent) Dr. Peter Kirchner, DOE Dr. T. G. Patel, VHA Dr. Richard Pazdur, FDA (absent) Dr. John F. Potter, DOD Dr. R. Julian Preston, EPA (absent) Dr. Anita Schill, NIOSH (absent) Dr. Donald Wright, OSHA